How to Help Your Patients Find Pancreaze in Stock: A Provider's Guide

For clinicians managing exocrine pancreatic insufficiency (EPI) patients, medication access is as important a clinical variable as dosing. Pancreaze (pancrelipase) must be taken with every meal and snack — missed doses translate directly to malabsorption, malnutrition, and worsening clinical outcomes. When pharmacy access becomes a barrier, it requires a clinical response.

This guide gives gastroenterologists, pulmonologists, CF specialists, and primary care providers a practical toolkit for helping Pancreaze patients navigate the current supply landscape.

Why Access Problems Happen Even Without a Formal Shortage

Pancreaze is not on the FDA's official shortage list as of 2026, and VIVUS reports coverage on 81% of commercial plans. Yet your patients are still calling your office because they can't get their prescription filled. Here's why:

• Not every pharmacy stocks all six Pancreaze strengths. Pharmacies typically carry what they regularly dispense, and slow-moving strengths may not be kept on hand.
• Supply chain disruptions to Creon (AbbVie) since 2022 have pushed patients to other PERT products, creating increased demand on Pancreaze inventory at some distributors.
• EPI patients take PERT with every meal — high daily volume means pharmacies cycle through inventory quickly.
• No generic exists for any pancrelipase product — there's no overflow option when brand supply is tight.

Step 1: Confirm the Specific Strength and Quantity Needed

When a patient reports they can't find Pancreaze, confirm exactly what they need:

• Pancreaze strength (lipase units per capsule: 2,600; 4,200; 10,500; 16,800; 21,000; or 37,000)
• Quantity needed (e.g., 300 capsules for a 30-day supply)
• Insurance plan and whether prior authorization is in place for Pancreaze specifically

This information is critical for any pharmacy search or alternative prescribing decision.

Step 2: Direct Patients to medfinder for Pharmacy Searches

Rather than having patients call 10 pharmacies one by one, medfinder does that work for them. Patients enter their medication, dosage, and location, and medfinder contacts nearby pharmacies to determine which ones can fill the prescription. Results are texted to the patient. This can save hours and eliminate the frustration of being passed from voicemail to voicemail.

Consider adding a referral to medfinder to your EPI patient intake and follow-up workflow — particularly for patients on high doses who go through medication quickly.

Step 3: Build a Preferred Pharmacy Referral List

Identify 2–3 pharmacies in your practice area that reliably stock all Pancreaze strengths. This is typically:

• A specialty pharmacy that focuses on GI or CF patients
• An independent pharmacy with multiple distributors
• A hospital outpatient pharmacy with access to acute-care supply chains

Keeping this list in your patient handout packet or EHR care plan saves time when patients inevitably encounter access issues.

Step 4: Have Alternative PERT Prescriptions Ready to Issue

For patients at risk of supply interruptions, proactively document the equivalent dose in an alternative PERT product in their chart. This way, if Pancreaze is unavailable, your staff can issue a new prescription for Creon, Zenpep, or Pertzye without requiring a new clinical decision under time pressure.

Dose conversion reference (lipase units per capsule, starting points — adjust based on clinical response):

• Pancreaze 10,500 ≈ Creon 12,000 (1 cap/meal) or Zenpep 10,000 (1 cap/meal)
• Pancreaze 16,800 ≈ Creon 12,000 (2 caps/meal) or Zenpep 15,000 (1 cap/meal)
• Pancreaze 21,000 ≈ Creon 24,000 (1 cap/meal) or Zenpep 20,000 (1 cap/meal)

Always verify these conversions against the latest full prescribing information for each product and individualize based on the patient's fat intake, body weight, and symptom response.

Step 5: Address Cost as a Barrier

For commercially insured patients, the Pancreaze Savings Card (updated Feb 1, 2026) offers up to $2,000 off per prescription fill with a maximum yearly benefit of $3,500. Eligible patients may pay as little as $0 per fill. This can be particularly valuable if insurance coverage lapses or if a patient is in a coverage gap.

For uninsured or underinsured patients, the Pancreaze Patient Assistance Program (via VIVUS, 1-855-751-5540) provides medication at no charge for eligible patients. The HealthWell Foundation Cystic Fibrosis Fund (1-800-675-8416) offers additional support for CF patients with insurance.

Proactive Practice-Level Adjustments

Consider incorporating these system-level adjustments into your practice:

• Add alternative PERT prescriptions to standing orders or patient care plans for EPI patients.
• Send EPI patients for 90-day supply prescriptions through mail order when possible.
• Include patient education on medfinder and pharmacy-finding strategies in your EPI discharge paperwork.
• Flag patients with a history of access issues for proactive outreach at each appointment.

For more detail on the current PERT supply situation, see our clinical briefing: Pancreaze Shortage: What Providers and Prescribers Need to Know in 2026.